Monday November 18, 2019 10:49

Heathcare Press Release : 04 Nov 2015

Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Heathcare—04 Nov 15

- Complements Allergan's leadership position in Medical Aesthetics and enhances offering to Plastic Surgeons - earFold(TM), for the correction of prominent ears and/or ear asymmetry in people aged 7 years and older,[1] was recently granted a CE mark for

ViiV Healthcare Announces Positive Headline Results from a Study of Two Drug Injectable Regimen for Heathcare—04 Nov 15

ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today announced that the Phase IIb study LATTE 2 (NCT02120352) met its primary endpoint at 32 weeks. These results show that the investigational,

First Investigational All Injectable Long Acting HIV Combination Regimen Study Results at 32 Weeks Heathcare—04 Nov 15

Injectable combinations once every 4 or 8 weeks show comparable efficacy versus daily oral combination therapy Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced that Phase IIb data